Term Name:	ABBV-951
Synonyms:	ABBV 951, ABBV951, foscarbidopa/foslevodopa, foslevodopa/foscarbidopa
Definition:	A mixture comprising of foslevodopa and foscarbidopa, two prodrugs which are metabolized into levodopa and carbidopa. It is developed by Abbvie for the treatment for Parkinson's disease and is administered through a continuous subcutaneous (under-the-skin) infusion via a portable pump.
Ontology:	ChEBI [CHEBI:192512]  ( EBI )